Business, Education

Wiley announces quarterly dividend

Wiley Announces Quarterly Dividend, HOBOKEN, N.J.–(BUSINESS WIRE)–John Wiley and Sons (NYSE:JWA)(NYSE:JWB), a global research and education company, today announced that its Board of Directors has declared a quarterly cash dividend of $0.3425 per share on its Class A and Class B Common

Business, Health Care

Immetas Therapeutics announces Series A financing to advance research on inflammation pathways in aging and develop therapeutics for cancer and inflammatory disease

Immetas Therapeutics Announces Series A Financing to Advance Research on Inflammation Pathways in Aging and Develop Therapeutics for Cancer and Inflammatory Disease, EAST HANOVER, N.J.–(BUSINESS WIRE)–Immetas Therapeutics today announced it has raised a Series A financing of $11 million to advance research

Business, Health Care

LYNPARZA reduced risk of death by 31% vs. Enzalutamide or Abiraterone for men with BRCA1/2 or ATM-mutated metastatic castration resistant prostate cancer who progressed following enzalutamide or abiraterone in Phase 3 PROfound trial

LYNPARZA is the Only PARP Inhibitor to Demonstrate Improved Overall Survival in Metastatic Castration-Resistant Prostate Cancer KENILWORTH, N.J.–(BUSINESS WIRE)–$MRK #MRK–AstraZeneca and Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced final results from the Phase 3 PROfound